HMG-CoA reductase inhibitors (statins), inflammation, and endothelial progenitor cells-New mechanistic insights of atherosclerosis (Q38235417)

31 August 2017

title

HMG-CoA reductase inhibitors (statins), inflammation, and endothelial progenitor cells-New mechanistic insights of atherosclerosis (English)

1 reference

31 August 2017

0 references

0 references

1 reference

Arnon Blum

1

1 reference

31 August 2017

publication date

1 May 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

40

1 reference

31 August 2017

issue

3

1 reference

31 August 2017

page(s)

295-302

1 reference

The immune response in atherosclerosis: a double-edged sword

31 August 2017

cites work

1 reference

Innate and adaptive immunity in the pathogenesis of atherosclerosis

21 January 2018

1 reference

P-selectin glycoprotein ligand-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice

21 January 2018

1 reference

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

21 January 2018

1 reference

Intertwining of thrombosis and inflammation in atherosclerosis

21 January 2018

1 reference

Inflammation in atherosclerosis: from pathophysiology to practice

21 January 2018

1 reference

The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis

21 January 2018

1 reference

Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.

21 January 2018

1 reference

Disruption of TGF-β signaling in T cells accelerates atherosclerosis

21 January 2018

1 reference

Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model

21 January 2018

1 reference

C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus

21 January 2018

1 reference

Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial

21 January 2018

1 reference

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

Inhibition of lipoprotein-associated phospholipase activity by darapladib: shifting gears in cardiovascular drug development: are antiinflammatory drugs the next frontier?

21 January 2018

1 reference

Lipid lowering and HDL raising gene transfer increase endothelial progenitor cells, enhance myocardial vascularity, and improve diastolic function

21 January 2018

1 reference

Low-density lipoprotein receptor gene transfer in hypercholesterolemic mice improves cardiac function after myocardial infarction

21 January 2018

1 reference

Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days

21 January 2018

1 reference

Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.

21 January 2018

1 reference

HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells

21 January 2018

1 reference

Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease

21 January 2018

1 reference

Inhibition of Hydroxymethylglutaryl-Coenzyme A Reductase Reduces Th1 Development and Promotes Th2 Development

21 January 2018

1 reference

Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation

21 January 2018

1 reference

Endothelial function and coronary artery disease

21 January 2018

1 reference

Hypertension, angiotensin II, and oxidative stress

21 January 2018

1 reference

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

21 January 2018

1 reference

Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria.

21 January 2018

1 reference

Statin therapy improves brachial artery endothelial function in nephrotic syndrome.

21 January 2018

1 reference

Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients

21 January 2018

1 reference

The effect of statin therapy on endothelial function in type 2 diabetes without manifest cardiovascular disease

21 January 2018

1 reference

Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance

21 January 2018

1 reference

HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species

21 January 2018

1 reference

Beneficial cardiovascular pleiotropic effects of statins

21 January 2018

1 reference

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

21 January 2018

1 reference

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

The oxidative modification hypothesis of atherosclerosis: does it hold for humans?

21 January 2018

1 reference

Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy

21 January 2018

1 reference

Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction

21 January 2018

1 reference

Early initiation of treatment with statins in acute coronary syndromes

21 January 2018

1 reference

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

21 January 2018

1 reference

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

21 January 2018

1 reference

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study

21 January 2018

1 reference

Prognostic value of coronary vascular endothelial dysfunction

21 January 2018

1 reference

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

21 January 2018

1 reference

HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells

21 January 2018

1 reference

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

21 January 2018

1 reference

Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease

21 January 2018

1 reference

Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase

21 January 2018

1 reference

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

21 January 2018

1 reference

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

21 January 2018

1 reference

Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells

21 January 2018

1 reference

Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury

21 January 2018

1 reference

Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women

21 January 2018

1 reference

Microarray-based characterization of a colony assay used to investigate endothelial progenitor cells and relevance to endothelial function in humans

21 January 2018

1 reference

Transcriptional profiling of CD133(+) cells in coronary artery disease and effects of exercise on gene expression.

21 January 2018

1 reference

Atorvastatin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase.

21 January 2018

1 reference

Vasculoprotective effects of combined endothelial progenitor cells and mesenchymal stem cells in diabetic wound care: their potential role in decreasing wound-oxidative stress

21 January 2018

1 reference

Natural regulatory T cells control the development of atherosclerosis in mice

21 January 2018

1 reference

Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain

21 January 2018

1 reference

Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BIOF.1157

1 reference

31 August 2017

1 reference